1. Home
  2. CDT vs JWEL Comparison

CDT vs JWEL Comparison

Compare CDT & JWEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDT
  • JWEL
  • Stock Information
  • Founded
  • CDT 2019
  • JWEL 2012
  • Country
  • CDT United States
  • JWEL China
  • Employees
  • CDT N/A
  • JWEL N/A
  • Industry
  • CDT Biotechnology: Pharmaceutical Preparations
  • JWEL Other Consumer Services
  • Sector
  • CDT Health Care
  • JWEL Consumer Discretionary
  • Exchange
  • CDT Nasdaq
  • JWEL Nasdaq
  • Market Cap
  • CDT 4.6M
  • JWEL 3.8M
  • IPO Year
  • CDT N/A
  • JWEL 2021
  • Fundamental
  • Price
  • CDT $0.77
  • JWEL $1.81
  • Analyst Decision
  • CDT
  • JWEL
  • Analyst Count
  • CDT 0
  • JWEL 0
  • Target Price
  • CDT N/A
  • JWEL N/A
  • AVG Volume (30 Days)
  • CDT 11.5M
  • JWEL 25.1K
  • Earning Date
  • CDT 11-13-2025
  • JWEL 05-09-2025
  • Dividend Yield
  • CDT N/A
  • JWEL N/A
  • EPS Growth
  • CDT N/A
  • JWEL N/A
  • EPS
  • CDT N/A
  • JWEL N/A
  • Revenue
  • CDT N/A
  • JWEL $132,981,531.00
  • Revenue This Year
  • CDT N/A
  • JWEL N/A
  • Revenue Next Year
  • CDT N/A
  • JWEL N/A
  • P/E Ratio
  • CDT N/A
  • JWEL N/A
  • Revenue Growth
  • CDT N/A
  • JWEL N/A
  • 52 Week Low
  • CDT $0.57
  • JWEL $1.45
  • 52 Week High
  • CDT $274.80
  • JWEL $3.71
  • Technical
  • Relative Strength Index (RSI)
  • CDT 41.63
  • JWEL 44.17
  • Support Level
  • CDT $0.65
  • JWEL $1.70
  • Resistance Level
  • CDT $0.89
  • JWEL $1.78
  • Average True Range (ATR)
  • CDT 0.07
  • JWEL 0.11
  • MACD
  • CDT 0.05
  • JWEL 0.00
  • Stochastic Oscillator
  • CDT 46.72
  • JWEL 40.00

About CDT Conduit Pharmaceuticals Inc.

CDT Equity Inc, formerly Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

About JWEL Jowell Global Ltd.

Jowell Global Ltd is a cosmetics, health, nutritional supplements, and household products e-commerce platform in China. The company offers its branded products to customers and also sells and distributes products from other companies on its platform. In addition, it allows third parties to open their stores on its platform for a service fee based on their sales revenues generated from their online stores and provides them with information about market needs, enabling them to manage their sales effort, as well as an effective platform to promote their brands. The company currently operates under four sales channels: Online Direct Sales, Authorized Retail Store Distribution, Third-party Merchants, and Live streaming marketing. Geographically, it generates all of its revenue from the PRC.

Share on Social Networks: